$336.09
0.96% yesterday
NYSE, Nov 25, 10:10 pm CET
ISIN
US0905721082
Symbol
BIO
Sector

Bio-Rad Laboratories, Inc. Class B Stock price

$336.09
+15.86 4.95% 1M
+48.88 17.02% 6M
+13.20 4.09% YTD
+28.95 9.43% 1Y
-400.71 54.39% 3Y
-32.74 8.88% 5Y
+217.14 182.55% 10Y
NYSE, Closing price Mon, Nov 25 2024
+3.18 0.96%
ISIN
US0905721082
Symbol
BIO
Sector

Key metrics

Market capitalization $9.41b
Enterprise Value $9.17b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 37.19
EV/Sales (TTM) EV/Sales 3.55
P/S ratio (TTM) P/S ratio 3.65
P/B ratio (TTM) P/B ratio 1.26
Revenue growth (TTM) Revenue growth -5.15%
Revenue (TTM) Revenue $2.58b
EBIT (operating result TTM) EBIT $344.46m
Free Cash Flow (TTM) Free Cash Flow $246.55m
Cash position $1.63b
EPS (TTM) EPS $-27.33
P/E forward 32.60
P/S forward 3.65
EV/Sales forward 3.55
Short interest 3.76%
Show more

Is Bio-Rad Laboratories, Inc. Class B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Bio-Rad Laboratories, Inc. Class B Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

4x Buy
57%
3x Hold
43%

Analyst Opinions

7 Analysts have issued a Bio-Rad Laboratories, Inc. Class B forecast:

Buy
57%
Hold
43%

Financial data from Bio-Rad Laboratories, Inc. Class B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,580 2,580
5% 5%
100%
- Direct Costs 1,176 1,176
7% 7%
46%
1,404 1,404
4% 4%
54%
- Selling and Administrative Expenses 616 616
2% 2%
24%
- Research and Development Expense 247 247
7% 7%
10%
541 541
10% 10%
21%
- Depreciation and Amortization 197 197
2% 2%
8%
EBIT (Operating Income) EBIT 344 344
13% 13%
13%
Net Profit -779 -779
389% 389%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about Bio-Rad Laboratories, Inc. Class B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bio-Rad Laboratories, Inc. Class B Stock News

Neutral
Business Wire
5 days ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will host one-on-one meetings with analysts and investors during Citi's 2024 Global Healthcare Conference in Miami,...
Neutral
Business Wire
26 days ago
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K. Lakkaraju will participate in a fireside chat event during the UBS Global Healthcare Conference on Wednesday, November 13, 20...
Neutral
Seeking Alpha
27 days ago
Bio-Rad Laboratories, Inc. (NYSE:BIO ) Q3 2024 Earnings Conference Call October 30, 2024 5:00 PM ET Company Participants Edward Chung - Vice President of Investor Relations Norman Schwartz - Chairman of the Board, President & Chief Executive Officer Jon DiVincenzo - President & Chief Operating Officer Roop Lakkaraju - Executive Vice President & Chief Financial Officer Conference Call Participan...
More Bio-Rad Laboratories, Inc. Class B News

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Head office United States
CEO Norman Schwartz
Employees 8,030
Founded 1952
Website www.bio-rad.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today